Boron trifluoride etherate → 4-Pentenal diethyl acetal

HRID 324679

Reaktionsgleichung

Reaktionsgleichung von HRID 324679
B(F)(F)F.[CH3:5]COCC.C(=O)CCC=C.[CH3:16][C@@H:17]1[O:22][C@@H:21]([O:23][C@@H:24]2[C:29]3=C(O)C4C(=O)C5C(=CC=CC=5OC)C(=O)C=4C(O)=C3C[C@@](O)(C(CO)=O)C2)[CH2:20][C@H:19](N)[C@@H:18]1O>C(O)C>[CH2:24]([O:23][CH:21]([O:22][CH2:17][CH3:16])[CH2:20][CH2:19][CH:18]=[CH2:5])[CH3:29]

Komponenten

5

Versuchsvorschrift

Boron trifluoride diethyl etherate (0.2 mL) was added, with stirring, to a solution of 4-pentenal (Cherif, A.; Farquhar, D. N-(5,5-diacetoxypent-1-yl)doxorubicin: A new intensely potent doxorubicin analogue. J. Med. Chem. 35, 3208-3214 (1992)) (2.5 g, 29.8 mmol) in ethanol (150 mL). The mixture was refluxed for 10 min under nitrogen, then the ethanol was removed under reduced pressure. The residue was taken up in dichloromethane (25 mL), and the solution was washed with 10% sodium acetate solution (15 mL) and water (2×10 mL). The organic layers were combined, dried over anhydrous sodium sulfate, and evaporated. The residue was chromatographed on a column of silica gel using chloroform/methanol (97:3) as eluent. 4-Pentenal diethyl acetal was obtained as an oil (4.5 g, 96%). 1H NMR (CDCl3) δ 5.88-5.61 (m, 1 H, H4), 5.03-4.87 (m, 2 H, H5), 4.38 (t, 1 H, J=7, H1), 3.30-3.61(m, 4 H, 2×CH2), 2.07-1.96 (m, 2 H, H2), 1.64-1.53 (m, 2 H, H3), 1.09 (t, 6 H, J=7, 2×CH3).

Aufarbeitung

  1. temperatureThe mixture was refluxed for 10 min under nitrogen
  2. customthe ethanol was removed under reduced pressure
  3. washthe solution was washed with 10% sodium acetate solution (15 mL) and water (2×10 mL)
  4. dry with materialdried over anhydrous sodium sulfate
  5. customevaporated
  6. customThe residue was chromatographed on a column of silica gel

Quellen und Nachweise

ORD-Eintrag
ord-d93eb0a365844c8d9b062230673c7ea9
Quelldatensatz
uspto-grants-2001_04
Patentnummer
US06218519B1

Verknüpfte Notizen

Wird geladen…